Opinion
YZi Labs Slams CEA Industries’ Poison Pill as Boardroom Tensions Escalate
Nasdaq-listed CEA Industries is facing growing pressure from one of its most prominent investors, as Changpeng Zhao-backed YZi Labs publicly criticized the company’s recent governance moves, deepening a boardroom dispute that has unfolded rapidly over the past month. In a post shared Wednesday on X, YZi Labs condemned CEA